Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by canadapieton Jan 14, 2021 3:40am

230 Views

Post# 32291996

IR Mrs Leah

Halo MB,

any questions to ask our leading IR woman???

Dear Piet,

Thank you for your email and apologies for the delay in getting back to you.

In regards to your questions below, please let me know if you would like to schedule some time for the two of us to chat via phone.

Regards,
Leah

Dear MB,

any questions to ask our leading IR woman???

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project